EGPA - Eosinophilic Granulomatosis With Polyangiitis research hub

Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis

This study looks at a new drug, tezepelumab, for a rare condition called EGPA. It aims to see if the drug works and how it affects the body in adults with EGPA, helping them reduce steroid use.